Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 85

1.

Inflammation, obesity, stress and coronary heart disease: is interleukin-6 the link?

Yudkin JS, Kumari M, Humphries SE, Mohamed-Ali V.

Atherosclerosis. 2000 Feb;148(2):209-14. Review.

PMID:
10657556
2.

Platelet-derived interleukin-1 induces cytokine production, but not proliferation of human vascular smooth muscle cells.

Loppnow H, Bil R, Hirt S, Schönbeck U, Herzberg M, Werdan K, Rietschel ET, Brandt E, Flad HD.

Blood. 1998 Jan 1;91(1):134-41.

3.

Recent advances in the relationship between obesity, inflammation, and insulin resistance.

Bastard JP, Maachi M, Lagathu C, Kim MJ, Caron M, Vidal H, Capeau J, Feve B.

Eur Cytokine Netw. 2006 Mar;17(1):4-12. Review.

6.

High-sensitivity C-reactive protein and atherosclerotic disease: from improved risk prediction to risk-guided therapy.

Koenig W.

Int J Cardiol. 2013 Oct 15;168(6):5126-34. doi: 10.1016/j.ijcard.2013.07.113. Epub 2013 Aug 24. Review.

PMID:
23978367
7.

Macrophage colony-stimulating factor gene expression in vascular cells and in experimental and human atherosclerosis.

Clinton SK, Underwood R, Hayes L, Sherman ML, Kufe DW, Libby P.

Am J Pathol. 1992 Feb;140(2):301-16.

8.

Pro-inflammatory cytokines and adipose tissue.

Coppack SW.

Proc Nutr Soc. 2001 Aug;60(3):349-56. Review.

PMID:
11681809
9.

C-reactive protein, fibrinogen, interleukin-6 and tumour necrosis factor-alpha in the prognostic classification of unstable angina pectoris.

Koukkunen H, Penttilä K, Kemppainen A, Halinen M, Penttila I, Rantanen T, Pyörälä K.

Ann Med. 2001 Feb;33(1):37-47.

PMID:
11310937
10.

Modulation of hepatic inflammatory risk markers of cardiovascular diseases by PPAR-alpha activators: clinical and experimental evidence.

Zambon A, Gervois P, Pauletto P, Fruchart JC, Staels B.

Arterioscler Thromb Vasc Biol. 2006 May;26(5):977-86. Epub 2006 Jan 19. Review.

11.

Plasma levels of C1q/TNF-related protein 1 and interleukin 6 in patients with acute coronary syndrome or stable angina pectoris.

Tang JN, Shen DL, Liu CL, Wang XF, Zhang L, Xuan XX, Cui LL, Zhang JY.

Am J Med Sci. 2015 Feb;349(2):130-6. doi: 10.1097/MAJ.0000000000000378.

PMID:
25635749
12.

Cooperation of liver cells in health and disease.

Kmieć Z.

Adv Anat Embryol Cell Biol. 2001;161:III-XIII, 1-151. Review.

PMID:
11729749
13.

Atherosclerosis and inflammation. Patterns of cytokine regulation in patients with peripheral arterial disease.

Fiotti N, Giansante C, Ponte E, Delbello C, Calabrese S, Zacchi T, Dobrina A, Guarnieri G.

Atherosclerosis. 1999 Jul;145(1):51-60.

PMID:
10428295
15.

Inflammation, thrombosis and acute coronary syndromes.

Carter AM.

Diab Vasc Dis Res. 2005 Oct;2(3):113-21. Review.

PMID:
16334592
17.

The influence of obesity and consequent insulin resistance on coronary risk factors in medically treated patients with coronary disease.

Ades PA, Savage PD, Toth MJ, Schneider DJ, Audelin MC, Bunn JY, Ludlow M.

Int J Obes (Lond). 2008 Jun;32(6):967-74. doi: 10.1038/ijo.2008.6. Epub 2008 Feb 12.

PMID:
18268512
18.

Relation of serum cytokine concentrations to cardiovascular risk factors and coronary heart disease.

Mendall MA, Patel P, Asante M, Ballam L, Morris J, Strachan DP, Camm AJ, Northfield TC.

Heart. 1997 Sep;78(3):273-7.

19.

New paradigms in neuroendocrinology: relationships between obesity, systemic inflammation and the neuroendocrine system.

Toni R, Malaguti A, Castorina S, Roti E, Lechan RM.

J Endocrinol Invest. 2004 Feb;27(2):182-6. Review.

PMID:
15129816

Supplemental Content

Support Center